I strongly believe that Neuren need to better promote their successes with more brokers to attract a larger market of buyers. The reason why most Pharma in Australia tend to plod along is due to zero marketing ability.
Ann: Successful Phase 1 trial for Neuren's NNZ-2591, page-9
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.75 |
Change
0.000(0.00%) |
Mkt cap ! $1.757B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1290 | $14.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.07 | 496 | 2 |
View Market Depth
| Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable